Amarin Corp Plc (AMRN)

[CaptBeer]

Most of you know that the results from the PREPARE RCT (PRevention Using EPA Against coloREctal) was released last week at: https://clinicaltrials.gov/study/NCT04216251

Personal communication with the PI informed me that a peer reviewed publication would be forthcoming before year end. In the meantime, I prepared this slide to illustrate the Primary Outcome Measure: Change in the Marine Omega-3 Polyunsaturated Fatty Acid (MO3PUFA) Composition in Colorectal Tissues as a Result of the AMR101 (VASCEPA) Treatment. [Time Frame: 8-12 weeks]

It is believed that EPA acts as a “chemopreventive” agent to reduce the risk of CRC in patients with a history of CRC. These results look impressive to me. I guess we’ll wait for the expert’s opinions.